Patents by Inventor Jeremy J. Kroll

Jeremy J. Kroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140011210
    Abstract: The invention provides immunogenic compositions useful for inhibiting, treating, protecting, or preventing infection by Actinobacillus suis. These immunogenic compositions are demonstrated to usefully stimulate immunogenic responses in treated pigs. Some vaccines stimulated reactions sufficient to be protective against A. suis. In addition, the invention provides kits comprising the immunogenic compositions; as well as, methods of using the compositions and kits.
    Type: Application
    Filed: September 16, 2013
    Publication date: January 9, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Jeremy J. KROLL, Philip UTLEY, Dianna M. Murphy JORDAN
  • Publication number: 20130164332
    Abstract: The present invention provides improved vaccination methods for increased protection against ileitis. The methods provide for the vaccination of young animals, preferably piglets, between 10 and 26 days of age, vaccination of pregnant sows during the second or third stages of gestation, and a combination of these methods. Vaccination of the pregnant sows can occur using repeated and/or high doses of Lawsonai antigen prior to farrowing.
    Type: Application
    Filed: February 18, 2013
    Publication date: June 27, 2013
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Jeremy J. KROLL, Michael B. ROOF
  • Patent number: 7758870
    Abstract: The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of L. intracellularis, including both a novel isolate of L. intracellularis of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: July 20, 2010
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael B. Roof, Jeremy J. Kroll, Jeffrey P. Knittel
  • Patent number: 7550270
    Abstract: Improved immunoassays for the protection of antibodies against Lawsonia intracellularis are provided which permit rapid, easy detection of low concentrations of anti-Lawsonia antibodies in animal-derived specimens. The preferred assay is an ELISA assay employing an antigenic extract of L. intracellularis lipopolysaccharide.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: June 23, 2009
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Jeremy J. Kroll, Michael B. Roof, Marc A. Eichmeyer
  • Publication number: 20080112980
    Abstract: The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of L. intracellularis, including both a novel isolate of L. intracellularis of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.
    Type: Application
    Filed: November 6, 2007
    Publication date: May 15, 2008
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael B. Roof, Jeremy J. Kroll, Jeffrey P. Knittel
  • Patent number: 7312065
    Abstract: The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of L. intracellularis, including both a novel isolate of L. intracellularis of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: December 25, 2007
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael B. Roof, Jeremy J. Kroll, Jeffrey P. Knittel